Insider Trading activities at Colucid Pharmaceuticals, Inc. (CLCD)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Colucid Pharmaceuticals, Inc. (CLCD) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Colucid Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1348649.

Total stock buying since 2015: $23,053,272.
Total stock sales since 2015: $5,274,888.
Total stock option exercises since 2015: $492,518.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Colucid Pharmaceuticals, Inc.* (*CLCD*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2017	0	$0	6,327	$224,457	6,335	$23,014
2016	100,000	$2,000,000	533,652	$5,050,431	121,494	$382,222
2015	2,107,500	$21,053,272	0	$0	199,927	$87,282

Table 2. Monthly summary of insider trading at *Colucid Pharmaceuticals, Inc.* (*CLCD*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2017-01	0	$0	6,327	$224,457	6,335	$23,014
2016-12	0	$0	2,245	$78,989	0	$0
2016-11	0	$0	4,083	$117,670	6,336	$23,021
2016-10	0	$0	4,083	$151,747	6,336	$23,021
2016-09	100,000	$2,000,000	61,238	$1,245,964	52,492	$336,180
2016-08	0	$0	156,186	$1,319,940	3,755	$0
2016-07	0	$0	3,026	$28,407	3,755	$0
2016-06	0	$0	3,026	$21,351	3,756	$0
2016-05	0	$0	0	$0	45,064	$0
2016-04	0	$0	299,765	$2,086,363	0	$0
2015-11	0	$0	0	$0	180,254	$0
2015-08	7,500	$53,272	0	$0	0	$0
2015-05	2,100,000	$21,000,000	0	$0	14,145	$64,784
2015-03	0	$0	0	$0	5,528	$22,498

Table 3. Detailed insider trading at *Colucid Pharmaceuticals, Inc.* (*CLCD*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2017-01-05	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	34.90	52,424
2017-01-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,755	.00	0
2017-01-05	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	1,677	34.52	57,891
2017-01-05	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	1,677	10.00	16,770
2017-01-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	185	36.40	6,734
2017-01-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	185	7.56	1,398
2017-01-03	Kuca Bernice (Head,Clin. and Reg. Operations)	Sale	772	36.25	27,985
2017-01-03	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	718	36.25	26,027
2017-01-03	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	718	6.75	4,846
2017-01-03	Dallas Matthew D (Chief Financial Officer)	Sale	1,473	36.25	53,396
2016-12-01	Kuca Bernice (Head,Clin. and Reg. Operations)	Sale	772	35.22	27,189
2016-12-01	Dallas Matthew D (Chief Financial Officer)	Sale	1,473	35.17	51,800
2016-11-07	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	28.57	42,916
2016-11-07	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	1,677	28.52	47,829
2016-11-07	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	1,677	10.00	16,770
2016-11-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,755	.00	0
2016-11-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	185	28.95	5,355
2016-11-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	185	7.56	1,398
2016-11-01	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	719	30.00	21,570
2016-11-01	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	719	6.75	4,853
2016-10-05	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	37.08	55,694
2016-10-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,755	.00	0
2016-10-05	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	1,677	37.08	62,183
2016-10-05	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	1,677	10.00	16,770
2016-10-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	185	36.41	6,735
2016-10-04	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	185	7.56	1,398
2016-10-03	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	719	37.74	27,135
2016-10-03	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	719	6.75	4,853
2016-09-14	Mathers Thomas P. (Chief Executive Officer)	Sale	6,000	23.54	141,240
2016-09-09	Novo A/s (10% Owner)	Buy	100,000	20.00	2,000,000
2016-09-07	Mathers Thomas P. (Chief Executive Officer)	Sale	5,000	22.58	112,899
2016-09-06	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	19.50	29,289
2016-09-06	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Sale	48,736	19.75	962,536
2016-09-06	Hogan Linda C. (Head, Bus. Dev. and Strategy)	Option Ex	48,736	6.90	336,180
2016-09-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,756	.00	0
2016-08-31	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	150	10.86	1,629
2016-08-19	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	8.41	4,272
2016-08-10	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	8.30	4,216
2016-08-05	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	8.31	12,481
2016-08-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,755	.00	0
2016-08-03	Vitullo Nicole (10% Owner)	Sale	81,223	8.15	661,967
2016-08-02	Vitullo Nicole (10% Owner)	Sale	19,750	8.71	172,021
2016-08-01	Vitullo Nicole (10% Owner)	Sale	52,300	8.82	461,285
2016-07-29	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	9.09	4,615
2016-07-20	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	8.97	4,556
2016-07-11	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	9.10	4,622
2016-07-05	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	9.73	14,614
2016-07-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,755	.00	0
2016-06-30	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	516	7.01	3,617
2016-06-20	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	500	7.00	3,500
2016-06-10	Skwierczynski Raymond (Head,Pharmaceutical Operations)	Sale	508	6.60	3,351
2016-06-06	Mathers Thomas P. (Chief Executive Officer)	Sale	1,502	7.25	10,883
2016-06-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	3,756	.00	0
2016-05-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	45,064	.00	0
2016-04-28	Vitullo Nicole (10% Owner)	Sale	150,000	6.96	1,043,999
2015-11-05	Mathers Thomas P. (Chief Executive Officer)	Option Ex	180,254	.00	0
2015-08-25	Mathers Thomas P. (Chief Executive Officer)	Buy	7,500	7.10	53,272
2015-05-13	Rupniak Nadia (VP-Research and Development)	Option Ex	14,145	4.58	64,784
2015-05-11	Tvm Life Science Ventures Vii L.p. (10% Owner)	Buy	500,000	10.00	5,000,000
2015-05-11	Novo A/s (10% Owner)	Buy	1,300,000	10.00	13,000,000
2015-05-11	A.m. Pappas & Associates, Llc (10% Owner)	Buy	300,000	10.00	3,000,000
2015-03-23	A.m. Pappas & Associates, Llc (10% Owner)	Option Ex	5,528	4.07	22,498

Insider trading activities including stock purchases, stock sales, and option exercises of CLCD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Colucid Pharmaceuticals, Inc. (symbol CLCD, CIK number 1348649) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month